NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced the commercial unveiling of the nCounter® Pro Analysis System, the next generation of the nCounter instrument platform. The new system requires minimal bioinformatics support and includes a new operating system, modern cybersecurity improvements, helping to keep data secure from unauthorized access, corruption or theft, and an expansive menu to support biomanufacturing and translational research.
